Successful detailed tracking of major plant disease’s global spread
On Jun. 4, 2020, Agricultural Research Service scientists and their Oregon State University collaborators announced they had developed…
INOVIO and IVI Partnered with Seoul National University Hospital to start phase 1/2 clinical trial of COVID-19 DNA vaccine (INO-4800) in South Korea
On Jun. 4, 2020, INOVIO and Seoul National University Hospital announced a partnership to start a Phase 1/2…
iBio announced second COVID-19 vaccine program
On Jun. 4, 2020, iBio announced it had initiatied preclinical immunization studies for its second COVID-19 vaccine platform….
Virginia Tech researchers established a reverse genetics system to facilitate COVID-19 research
On Jun. 4, 2020, with funding from the Fralin Life Sciences Institute at Virginia Tech, researchers James Weger-Lucarelli…
Roche initiated initiates phase III clinical trial of Actemra/RoActemra plus remdesivir in hospitalised patients with severe COVID-19 pneumonia
On Jun. 4, 2020, Roche announced the initiation of a global phase III, randomised, double-blind, multicentre study (REMDACTA)…
NIH study ties stroke-related brain blood vessel abnormality to gut bacteria
On Jun. 3, 2020, in a nationwide study, NIH funded researchers found that the presence of abnormal bundles…
CEPI granted $141 million to consortium of Bharat Biotech and IVI to advance development of Chikungunya vaccine in collaboration with Ind-CEPI
On Jun. 3, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, in collaboration with Ind-CEPI, announced a new…
NIH reported early results show benefit of remdesivir for COVID-19
On Jun. 2, 2020, the NIH reported that early results showed that remdesivir benefited hospitalized patients with severe…
FDA cleared IND for iNKT Cells to treat COVID-19 patients
On Jun. 2, 2020, Agenus announced the FDA’s clearance of AgenTus’ IND application for an allogeneic iNKT therapy….
Pfizer established $500 million program to support continued biotechnology innovation
On Jun. 2, 2020, Pfizer announced the establishment of the Pfizer Breakthrough Growth Initiative, through which Pfizer will…
The USDA announced the first confirmed case of a dog in the US to test positive for SARS-CoV-2
On Jun. 2, 2020, the USDA announced the first confirmed case of SARS-CoV-2 (the virus that causes COVID-19)…
Albert Einstein College of Medicine awarded $1 million for COVID-19 research from the Price Family Foundation
On Jun. 2, 2020, Albert Einstein College of Medicine announced it had received a $1 million challenge grant…
Trevena announced collaboration with Imperial College London to evaluate TRV027 in COVID-19 patients
On Jun. 2, 2020, Trevena announced it had entered into a collaboration with Imperial College London to evaluate…
Resverlogix announced COVID-19 clinical trial program launch
On Jun. 1, 2020, Resverlogix announced that it is moving forward with a plan to further evaluate apabetaloneï¾’s…
Cytiva and Entos Pharmaceuticals work together to accelerate development of COVID19 vaccines
On Jun. 1, 2020, Entos Pharmaceuticals announced a partnership with Cytiva, formerly part of GE Healthcare Life Sciences….
The US Dept of Defense launched effort to collect COVID-19 convalescent plasma
On Jun. 1, 2020, U.S. Dept. of Defense announced it had begun an effort to collect 8,000 donated…
New Ebola outbreak detected in northwest Democratic Republic of the Congo
On Jun. 1, 2020, the Government of the Democratic Republic of the Congo announced that a new outbreak…
Gilead announced results from phase 3 trial of Remdesivir in patients with moderate COVID-19
On Jun. 1, 2020, Gilead Sciences announced topline results from the Phase 3 SIMPLE trial in hospitalized patients…
Emergent BioSolutions joined U.S. Government’s Warp Speed Program for COVID-19 vaccine development and manufacturing
On Jun. 1, 2020, Emergent BioSolutions announced it had been issued a task order under an existing contract…
Anixa Biosciences and OntoChem synthesized four potential Covid-19 drugs for testing in biological assays
On Jun. 1, 2020, Anixa Biosciences and OntoChem announced they had synthesized four potential Covid-19 compounds that will…
The USDA announced transition to preventive plan for virulent Newcastle disease in California
On Jun. 1, 2020, the USDA announced it is transitioning its virulent Newcastle disease (vND) efforts in southern…
Eli Lilly began world’s first study of a potential COVID-19 antibody treatment in humans
On Jun. 1, 2020, Eli Lilly announced patients had been dosed in the world’s first study of a…
Proteostasis Therapeutics announced in vitro data for PTI-129 as potential treatment candidate for COVID-19
On Jun. 1, 2020, Proteostasis Therapeutics announced results from in vitro studies evaluating the use of PTI-129 as…
FDA issued Emergency Use Authorization for Impella RP as therapy for COVID-19 patients with right heart failure
On Jun. 1, 2020, the FDA issued an emergency use authorization (EUA) for Impella RP to include patients…
Altimmune launched clinical trial of T-COVIDTM, an investigational intranasal immune modulator for treatment of patients with early COVID-19
On Jun. 1, 2020, Altimmune announced the FDA had authorized the Company to proceed with a clinical trial…
LabCorp launched new COVID-19 clinical trial site to connect patients with US research trials
On Jun. 1, 2020, LabCorpï¾® announced that Covance, its drug development business, had created COVID-19 Clinical Trial Connect…
FDA authorized OPKO Health clinical trial evaluating RAYALDEE in COVID-19 patients
On Jun. 1, 2020, OPKO Health announced the FDA had authorized OPKO to undertake a Phase 2 trial…
Tonix Pharma announced FUJIFILM Diosynth Biotechnologies to be nanufacturing partner for COVID-19 vaccine candidate TNX-1800
On Jun. 1, 2020, Tonix Pharmaceuticals announced an agreement whereby FUJIFILM Diosynth Biotechnologies will provide contract manufacturing and…
SIGA announced first international delivery of Oral TPOXX
On Jun. 1, 2020, SIGA Technologies announced its first international delivery of TPOXX (tecovirimat), with 2,500 courses delivered…
PathGroup announced new COVID-19 testing option
On Jun. 1, 2020, PathGroup announced the availability of a new, minimally-invasive nasal swab collection option as a…